9 Meters Biopharma, Inc.
9 Meters Biopharma, Inc., headquartered in the United States, is a pioneering biotechnology company focused on developing innovative therapies for patients with rare gastrointestinal diseases. Founded in 2018, the company has quickly established itself in the biopharmaceutical industry, particularly in the areas of drug development and clinical research. With a robust pipeline that includes unique oral therapies, 9 Meters Biopharma is dedicated to addressing unmet medical needs in conditions such as short bowel syndrome and celiac disease. Their flagship product, a novel treatment for short bowel syndrome, showcases their commitment to advancing patient care through cutting-edge science. Recognised for its rapid progress and strategic partnerships, 9 Meters Biopharma is positioned as a leader in the biopharma sector, striving to improve the quality of life for patients worldwide.
DitchCarbon Score
How does 9 Meters Biopharma, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
9 Meters Biopharma, Inc.'s score of 23 is lower than 77% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
9 Meters Biopharma, Inc.'s reported carbon emissions
9 Meters Biopharma, Inc., headquartered in the US, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. As a result, 9 Meters Biopharma does not appear to have established any significant climate commitments or initiatives aimed at reducing its carbon footprint. Without emissions data or reduction strategies, it is challenging to assess the company's environmental impact or its alignment with industry standards for sustainability. In the context of the biopharmaceutical industry, companies are increasingly expected to set ambitious climate targets and report on their emissions. However, 9 Meters Biopharma has yet to disclose any such commitments or inherited data from a parent organisation.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
9 Meters Biopharma, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
